Annual Accounts Payable
$1.45 M
+$274.00 K+23.38%
31 December 2023
Summary:
C4 Therapeutics annual accounts payable is currently $1.45 million, with the most recent change of +$274.00 thousand (+23.38%) on 31 December 2023. During the last 3 years, it has fallen by -$4.24 million (-74.56%). CCCC annual accounts payable is now -74.56% below its all-time high of $5.68 million, reached on 31 December 2020.CCCC Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.50 M
+$591.00 K+64.73%
30 September 2024
Summary:
C4 Therapeutics quarterly accounts payable is currently $1.50 million, with the most recent change of +$591.00 thousand (+64.73%) on 30 September 2024. Over the past year, it has increased by +$228.00 thousand (+17.87%). CCCC quarterly accounts payable is now -74.34% below its all-time high of $5.86 million, reached on 30 June 2020.CCCC Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.4% | +17.9% |
| 3 y3 years | -74.6% | -59.8% |
| 5 y5 years | +25.3% | - |
CCCC Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -74.6% | +23.4% | -66.6% | +64.7% |
| 5 y | 5 years | -74.6% | +25.3% | -74.3% | +64.7% |
| alltime | all time | -74.6% | +25.3% | -74.3% | +64.7% |
C4 Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.50 M(+64.7%) |
| June 2024 | - | $913.00 K(-44.0%) |
| Mar 2024 | - | $1.63 M(+12.7%) |
| Dec 2023 | $1.45 M(+23.4%) | $1.45 M(+13.3%) |
| Sept 2023 | - | $1.28 M(-43.2%) |
| June 2023 | - | $2.25 M(+117.3%) |
| Mar 2023 | - | $1.03 M(-11.8%) |
| Dec 2022 | $1.17 M | $1.17 M(-50.5%) |
| Sept 2022 | - | $2.37 M(-46.7%) |
| June 2022 | - | $4.45 M(+30.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $3.40 M(-24.4%) |
| Dec 2021 | $4.51 M(-20.7%) | $4.51 M(+20.3%) |
| Sept 2021 | - | $3.75 M(-16.2%) |
| June 2021 | - | $4.47 M(+19.4%) |
| Mar 2021 | - | $3.74 M(-34.2%) |
| Dec 2020 | $5.68 M(+5.5%) | $5.68 M(+8.0%) |
| Sept 2020 | - | $5.26 M(-10.2%) |
| June 2020 | - | $5.86 M(+8.8%) |
| Dec 2019 | $5.38 M(+366.6%) | $5.38 M |
| Dec 2018 | $1.15 M | - |
FAQ
- What is C4 Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for C4 Therapeutics?
- What is C4 Therapeutics annual accounts payable year-on-year change?
- What is C4 Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for C4 Therapeutics?
- What is C4 Therapeutics quarterly accounts payable year-on-year change?
What is C4 Therapeutics annual accounts payable?
The current annual accounts payable of CCCC is $1.45 M
What is the all time high annual accounts payable for C4 Therapeutics?
C4 Therapeutics all-time high annual accounts payable is $5.68 M
What is C4 Therapeutics annual accounts payable year-on-year change?
Over the past year, CCCC annual accounts payable has changed by +$274.00 K (+23.38%)
What is C4 Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CCCC is $1.50 M
What is the all time high quarterly accounts payable for C4 Therapeutics?
C4 Therapeutics all-time high quarterly accounts payable is $5.86 M
What is C4 Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CCCC quarterly accounts payable has changed by +$228.00 K (+17.87%)